Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zen Tech International BhdXKLS:0094 3-Year EBITDA Growth Rate is 51.00% as of Jun. 2026, which is 656% above its 10-year median of 6.75. The stock has 4 warning signs investors should review. Among 687 Medical Devices & Instruments companies, Zen Tech International Bhd ranks better than 88.5% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 51.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 34.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zen Tech International Bhd was 100.00% per year. The lowest was -81.70% per year. And the median was 6.75% per year.
Zen Tech International Bhd (XKLS:0094) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Zen Tech International Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:0094 vs ISRG, BDX, RMD: 3-Year EBITDA Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Zen Tech International Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zen Tech International Bhd 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zen Tech International Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Zen Tech International Bhd's 3-Year EBITDA Growth Rate falls into.
Zen Tech International Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 51.00% mean?
Zen Tech International Bhd (XKLS:0094) has a 3-Year EBITDA Growth Rate of 51.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Zen Tech International Bhd and its competitors. This is 656% above median its historical median of 6.75. According to the industry distribution chart, Zen Tech International Bhd ranks #79 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is Zen Tech International Bhd's 3-Year EBITDA Growth Rate too high?
Zen Tech International Bhd's current 3-Year EBITDA Growth Rate of 51.00% is 656% above median its 10-year median of 6.75. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 8.10. Zen Tech International Bhd's value of 51.00% is 529.6% above this industry median. Based on the distribution chart, Zen Tech International Bhd ranks #79 out of 687 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Zen Tech International Bhd's 3-Year EBITDA Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Zen Tech International Bhd ranks #79 out of 687 companies for 3-Year EBITDA Growth Rate. This places Zen Tech International Bhd in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.10. Zen Tech International Bhd's value of 51.00% is 529.6% above this benchmark. While the company's 10-year median is 6.75 vs. the industry median of 8.10, Zen Tech International Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.10, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zen Tech International Bhd's current 3-Year EBITDA Growth Rate of 51.00% is 529.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Zen Tech International Bhd and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zen Tech International Bhd's current 3-Year EBITDA Growth Rate is 51.00%, which is 656% above median its own 10-year median of 6.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zen Tech International Bhd stock overvalued right now?
Based on GuruFocus' analysis, Zen Tech International Bhd (XKLS:0094) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.01, compared to a current price of RM0.01 — trading 50% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 51.00%, which is 656% above median its 10-year median of 6.75 and 529.6% above the Medical Devices & Instruments industry median of 8.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Zen Tech International Bhd (XKLS:0094), the current 3-Year EBITDA Growth Rate is 51.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zen Tech International Bhd is a is Malaysia-based investment holding company. The company and its subsidiaries are predominantly engaged in software development, system integration, IT management consulting, and other related professional services. segments, The company operates in two business segments namely, Software and books, which comprises of software development and system integration solutions; the Gloves segment, which comprises the manufacturing of rubber gloves. Substantial portion of its overall revenue is generated from the Gloves segment and majority of its revenue is generated from the Malaysian market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0094 has been successfully added to your 
